Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Young America Capital is a FINRA/SEC licensed investment banking and advisory firm founded in 2010. The company provides capital raising, buy- and sell-side M&A advisory, and alternative investment services to early-stage and middle-market companies. While it has expertise in life sciences, healthcare, pharmaceutical, biopharmaceuticals, and medical devices among other sectors such as clean-tech and telecom/media/technology[2][8][10], it is not itself a biotech or pharma company but rather an advisor/broker-dealer serving these industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Young America Capital.